Director, Oncology ADC Chemistry & Team Leadership

Novartis Group Companies

Cambridge (MA)

Sur place

USD 186 000 - 345 000

Plein temps

14 jours+

Une candidature complète en une minute

Un CV et une lettre de motivation personnalisés, prêts à envoyer.

Passez les filtres ATS

Avantages offerts par ce poste

Insurance plans
Retirement plans
Wellbeing resources
Global recognition programs
Hybrid working options
14 weeks parental leave

Résumé du poste

Novartis Group Companies in Cambridge, MA is seeking a Director, Head of Antibody-Drug Conjugate Oncology Chemistry to lead the strategy and execution of ADC programs. You will guide multi-disciplinary teams across chemistry, biology and pharmacology to advance vectorized drug conjugates from discovery toward development milestones.

You will shape portfolio direction, mentor scientists, build strategic partnerships and foster an inclusive, high‑performance culture where bold ideas translate into

Qualifications

  • PhD required in Organic Chemistry, Medicinal Chemistry or closely related field.
  • 12+ years of pharma/biotech R&D with leadership experience.
  • Proven success advancing oncology drug discovery toward clinical development.
  • Deep knowledge of ADCs and vectorized drug conjugates.
  • Broad understanding of pharmacokinetics, toxicology and pharmacology.
  • Demonstrated ability to lead multidisciplinary teams and translate science into strategy.

Responsabilités

  • Lead medicinal chemistry strategy for ADC and vectorized programs across oncology portfolio.
  • Guide projects from exploration through candidate nomination.
  • Build, mentor and develop a high-performing chemistry team.
  • Partner with biology, biotherapeutics, PK, safety and process chemistry to advance programs.
  • Shape portfolio strategy, prioritization and resourcing in line with oncology goals.
  • Identify external collaborations and emerging technologies to strengthen discovery.
  • Foster an innovative and inclusive environment amidst complexity and change.

Connaissances

Leadership
Medicinal Chemistry
Organic Chemistry
Pharmacology
Drug Discovery
Cross-functional Leadership

Formation

Doctoral degree in Organic/Medicinal Chemistry

Outils

Computational chemistry tools
Structure-based drug design

Description du poste

Novartis Group Companies in Cambridge, MA is seeking a Director, Head of Antibody-Drug Conjugate Oncology Chemistry to lead the strategy and execution of ADC programs. You will guide multi-disciplinary teams across chemistry, biology and pharmacology to advance vectorized drug conjugates from discovery toward development milestones.

You will shape portfolio direction, mentor scientists, build strategic partnerships and foster an inclusive, high‑performance culture where bold ideas translate into

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Director, ADC Oncology Chemistry - Lead Discovery & Strategy
Director, ADC Oncology Chemistry - Lead Discovery & Strategy

Novartis • Cambridge (MA)

Sur place
USD 186 000 - 345 000
Hybrid working options
14 weeks parental leave
Competitive benefits
Director, ADC Oncology Chemistry — Lead Breakthrough Therapeutics
Director, ADC Oncology Chemistry — Lead Breakthrough Therapeutics

U175 (FCRS = US175) Novartis Institutes for BioMedical Research, Inc. • Cambridge (MA)

Sur place
USD 186 000 - 345 000
Flexible and hybrid working options
Minimum 14 weeks parental leave
Competitive benefits
Associate Director, ADC Platform Strategy - Oncology
Associate Director, ADC Platform Strategy - Oncology

U175 (FCRS = US175) Novartis Institutes for BioMedical Research, Inc. • Cambridge (MA)

Sur place
USD 153 000 - 283 000
Associate Director, ADC Platform Strategy
Associate Director, ADC Platform Strategy

Novartis Group Companies • Cambridge (MA)

Hybride
USD 152 600 - 283 400
Comprehensive benefits package
Performance-based cash incentive
Generous time off package
Associate Director, ADC platform in Oncology Drug Discovery
Associate Director, ADC platform in Oncology Drug Discovery

Novartis Group Companies • Cambridge (MA)

Sur place
USD 152 600 - 283 400
Comprehensive benefits package
Performance-based cash incentive
Generous time off package
Senior In Vivo Oncology Scientist – ADCs
Senior In Vivo Oncology Scientist – ADCs

Novartis Group Companies • Cambridge (MA)

Sur place
USD 126 000 - 234 000
Performance-based cash incentive
Health, life, and disability benefits
401(k) with company match
+1
Director, Bioconjugation
Director, Bioconjugation

Bristol Myers Squibb • Cambridge (MA)

Hybride
USD 190 000 - 270 000
Director of Bioconjugation & ADC/ARC Innovation
Director of Bioconjugation & ADC/ARC Innovation

Bristol Myers Squibb • Cambridge (MA)

Hybride
USD 190 000 - 270 000
Director, GDC Head of ADC Oncology Chemistry
Director, GDC Head of ADC Oncology Chemistry

Novartis Group Companies • Cambridge (MA)

Sur place
USD 186 000 - 345 000
Insurance plans
Retirement plans
Wellbeing resources
+3
Director of Toxicology, Oncology Safety & Radioconjugates
Director of Toxicology, Oncology Safety & Radioconjugates

AstraZeneca • Cambridge (MA)

Hybride
USD 185 000 - 277 000